President Trump on Monday nominated Susan Monarez, the acting director of the Centers for Disease Control and Prevention, to be the agency's full-time leader.
Why it matters: Monarez would be the first CDC director-designate to face Senate confirmation under a law Congress passed in 2023.
Why it matters: That financial distress has sparked a big question for some of the more than 15 million customers who have used the company's services: What does a sale mean for the genetic data 23andMe stores?
Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection and launched a sale process, just weeks after rejecting a takeover offer from co-founder and CEO Anne Wojcicki.
Why it matters: The writing was on the wall when 23andMe's independent directors quit last fall, but it's still stunning to witness the dysfunctional destruction of the rare biotech unicorn to become a household name.
The Trump administration wants to spend more federal dollars replicating medical research. A key question will be which studies get repeated and, with limited resources, at what expense.
Why it matters: Many findings can't be replicated— a problem scientists say needs to be addressed.But it could also consume increasingly scarce resources as the administration cuts spending and freezes federal grants.
After a 5-week hospital stay that triggered fears of a potential papal resignation, Pope Francis returned to the Vatican Sunday.
The big picture: But now, two months of rest and recovery prescribed by his doctors begin — just weeks out from Easter Sunday and the holiest days of the Catholic Church's year.
